Regeneron Pharmaceuticals... (REGN)
undefined
undefined%
At close: undefined
731.30
0.08%
After-hours Dec 13, 2024, 04:15 PM EST

Regeneron Pharmaceuticals Inc. Forcast

Stock Price Forecast

The 21 analysts with 12-month price forecasts for REGN stock have an median target of 1150, with a low estimate of 895 and a high estimate of 1300. The median target predicts an increase of 57.38% from the current stock price of 730.70.

Analyst Consensus: Buy
Target Low Average Median High
Price $895 $1126.65 $1150 $1300
Change 22.49% 54.19% 57.38% 77.91%

AI Analyst Report

RBC Capital maintains an Outperform rating for Reg... Unlock content with Pro Subscription

Updated Nov 01, 2024

Rating Jul 24Aug 24Sep 24Oct 24Nov 24Dec 24
Strong Buy 220000
Buy 357880
Hold 103110
Sell 000001
Strong Sell 000000
Total 6 7 10 9 9 1

Financial Forecast this Year

Revenue This Year
14.18B
from 13.12B
Increased by 8.1%
Revenue Next Year
15.31B
from 14.18B
Increased by 8.0%
EPS This Year
44.98
from 37.05
Increased by 21.4%
EPS Next Year
40.07
from 44.98
Increased by -10.9%